PF-Atlas › Clinical Trials › NCT06317363
Effects of Acapella VS CHEST Physiotherapy in Post-Operative CABG Patients
Base Line + ACEPELLA · Not specified
Registry ID
NCT06317363
Phase
Not specified
Status
Completed
Drug / intervention
Base Line + ACEPELLA
Sponsor
Riphah International University
Start
2023-05-23
About this trial
Base Line + ACEPELLA is evaluated in NCT06317363, a idiopathic pulmonary fibrosis study sponsored by Riphah International University. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT06317363 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.